| Product NDC: | 60505-0230 |
| Proprietary Name: | Nizatidine |
| Non Proprietary Name: | Nizatidine |
| Active Ingredient(s): | 150 mg/1 & nbsp; Nizatidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-0230 |
| Labeler Name: | Apotex Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076383 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030601 |
| Package NDC: | 60505-0230-1 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (60505-0230-1) |
| NDC Code | 60505-0230-1 |
| Proprietary Name | Nizatidine |
| Package Description | 30 CAPSULE in 1 BOTTLE (60505-0230-1) |
| Product NDC | 60505-0230 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nizatidine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030601 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp |
| Substance Name | NIZATIDINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |